Bayer Cropscience India Limited (IN:BAYERCROP)
:BAYERCROP
Want to see IN:BAYERCROP full AI Analyst Report?
Top Page
Bayer Cropscience India Limited
(BAYERCROP)
Select Model
Select Model
Rating:61Neutral
Price Target:
₹5,170.00
▲(14.67% Upside)
Action:ReiteratedDate:11/12/25
Bayer Cropscience India Limited's overall stock score is primarily influenced by its strong financial performance, characterized by stable revenue growth and a robust balance sheet. However, bearish technical indicators and a relatively high P/E ratio suggest caution. The stock's valuation and technical analysis indicate potential risks, while the absence of earnings call data and corporate events limits additional insights.
Positive Factors
Robust balance sheet
Extremely low leverage and a strong equity ratio provide durable financial flexibility. High cash and equivalents support working capital for seasonal ag cycles, fund R&D or seed inventory, and buffer against weather-driven revenue swings, reducing refinancing and solvency risk over months.
Negative Factors
Sharp margin compression
A large drop in gross and net margins signals structural cost pressures or pricing erosion that can persist across seasons. If input costs, mix shifts, or pricing challenges remain, margin recovery may be slow, constraining reinvestment, shareholder returns and the firm's ability to fund growth initiatives.
Read all positive and negative factors
Positive Factors
Negative Factors
Robust balance sheet
Extremely low leverage and a strong equity ratio provide durable financial flexibility. High cash and equivalents support working capital for seasonal ag cycles, fund R&D or seed inventory, and buffer against weather-driven revenue swings, reducing refinancing and solvency risk over months.
Read all positive factors
Bayer Cropscience India Limited (BAYERCROP) vs. iShares MSCI India ETF (INDA)
Market Cap
₹210.28B
Dividend Yield1.57%
Average Volume (3M)2.83K
Price to Earnings (P/E)53.5
Beta (1Y)0.94
Revenue Growth7.73%
EPS Growth28.75%
CountryIN
Employees1,317
SectorBasic Materials
Sector Strength58
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)21.30
Shares Outstanding44,942,093
10 Day Avg. Volume4,614
30 Day Avg. Volume2,834
Financial Highlights & Ratios
PEG Ratio-1.63
Price to Book (P/B)7.59
Price to Sales (P/S)3.95
P/FCF Ratio83.41
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)170.16
Revenue Forecast (FY)₹62.61B
Bayer Cropscience India Limited Business Overview & Revenue Model
Company Description
Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines ...
How the Company Makes Money
Bayer CropScience India Limited makes money primarily by selling agricultural inputs to customers in India through a distribution network of channel partners (e.g., distributors, dealers/retailers) and, in some cases, institutional/large-farm cust...
Bayer Cropscience India Limited Financial Statement Overview
Summary
Income Statement
75
Positive
Balance Sheet
85
Very Positive
Cash Flow
70
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 55.73B | 54.73B | 51.06B | 51.40B | 47.34B | 42.61B |
| Gross Profit | 21.43B | 20.59B | 21.81B | 23.09B | 20.57B | 17.99B |
| EBITDA | 7.12B | 6.43B | 9.43B | 8.86B | 7.90B | 7.80B |
| Net Income | 6.09B | 5.68B | 7.41B | 7.58B | 6.45B | 4.93B |
Balance Sheet | ||||||
| Total Assets | 51.91B | 52.46B | 45.97B | 46.79B | 43.53B | 42.39B |
| Cash, Cash Equivalents and Short-Term Investments | 7.16B | 9.29B | 12.11B | 9.02B | 8.19B | 12.57B |
| Total Debt | 1.02B | 1.05B | 471.00M | 735.00M | 864.00M | 263.00M |
| Total Liabilities | 20.68B | 23.95B | 17.48B | 19.66B | 18.29B | 16.89B |
| Stockholders Equity | 31.23B | 28.50B | 28.49B | 27.12B | 25.24B | 25.50B |
Cash Flow | ||||||
| Free Cash Flow | -682.00M | 2.59B | 9.06B | 5.32B | 1.60B | 6.45B |
| Operating Cash Flow | -349.00M | 3.00B | 9.52B | 6.09B | 2.15B | 6.87B |
| Investing Cash Flow | -90.00M | 389.00M | 4.00M | 833.00M | 642.00M | 67.00M |
| Financing Cash Flow | -1.84B | -6.10B | -6.56B | -6.13B | -7.03B | -5.56B |
Bayer Cropscience India Limited Technical Analysis
Positive
4508.60
Price Trends
4651.27
Positive
4558.68
Positive
4949.27
Negative
Market Momentum
89.82
Negative
60.47
Neutral
78.36
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BAYERCROP, the sentiment is Positive. The current price of 4508.6 is below the 20-day moving average (MA) of 4689.24, below the 50-day MA of 4651.27, and below the 200-day MA of 4949.27, indicating a neutral trend. The MACD of 89.82 indicates Negative momentum. The RSI at 60.47 is Neutral, neither overbought nor oversold. The STOCH value of 78.36 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:BAYERCROP.
Bayer Cropscience India Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ₹588.39B | 33.00 | ― | 0.50% | 32.40% | 45.45% | |
74 Outperform | ₹467.35B | 39.45 | ― | 0.49% | -12.56% | -14.61% | |
68 Neutral | ₹533.09B | 42.42 | ― | 0.77% | 8.72% | ― | |
62 Neutral | ₹176.44B | 8.23 | ― | 2.13% | 21.48% | 18.48% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ₹217.33B | 77.71 | ― | 0.26% | 2.89% | 3.04% | |
61 Neutral | ₹210.28B | 53.52 | ― | 1.57% | 7.73% | 28.75% |
* Basic Materials Sector Average
IN:BAYERCROP
Bayer Cropscience India Limited
4,613.30
-39.50
-0.85%
IN:CHAMBLFERT
Chambal Fertilisers & Chemicals Ltd.
448.25
-227.29
-33.65%
IN:COROMANDEL
Coromandel International Limited
2,009.05
-218.33
-9.80%
IN:PIIND
PI Industries Limited
3,100.15
-531.95
-14.65%
IN:SUMICHEM
Sumitomo Chemical India Ltd.
432.35
-70.88
-14.09%
IN:UPL
UPL Limited
645.45
-17.88
-2.70%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.